168 related articles for article (PubMed ID: 10984815)
21. Zidovudine monotherapy and the prevention of mother-to-child HIV-1 transmission.
Hudson CP
Lancet Infect Dis; 2005 Feb; 5(2):68. PubMed ID: 15680770
[No Abstract] [Full Text] [Related]
22. South African government threatens to ban nevirapine. Move would take away option for treating vertical HIV transmission.
Baleta A
Lancet; 2003 Aug; 362(9382):451. PubMed ID: 12927453
[No Abstract] [Full Text] [Related]
23. [Preventing the transmission of HIV-1 from mother to child in Africa in the year 2000].
Castetbon K; Leroy V; Spira R; Dabis F
Sante; 2000; 10(2):103-13. PubMed ID: 10960807
[TBL] [Abstract][Full Text] [Related]
24. Establishment of drug-resistant HIV-1 in latent reservoirs.
Dahl V; Palmer S
J Infect Dis; 2009 May; 199(9):1258-60. PubMed ID: 19338473
[No Abstract] [Full Text] [Related]
25. Preventing transmission of HIV from mother to child--is South Africa ready and willing?
Wilkinson D; McIntyre J
S Afr Med J; 1998 Oct; 88(10):1304-6. PubMed ID: 9807182
[No Abstract] [Full Text] [Related]
26. [Prevention of mother-to-child transmission with single dose nevirapine and human immunodeficiency virus drug resistance].
Han JF; Jiang Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):730-3. PubMed ID: 19031772
[No Abstract] [Full Text] [Related]
27. South Africa in crisis on HIV/AIDS treatment.
Jones TT
Science; 2001 Jun; 292(5526):2431-2. PubMed ID: 11441877
[No Abstract] [Full Text] [Related]
28. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
[TBL] [Abstract][Full Text] [Related]
29. Unequal care sustains vertical transmission rate.
Kasper T
GMHC Treat Issues; 1999 Feb; 13(2):11-2. PubMed ID: 11366115
[TBL] [Abstract][Full Text] [Related]
30. Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
Herzmann C; Karcher H
N Engl J Med; 2004 Nov; 351(19):2013-5; author reply 2013-5. PubMed ID: 15525729
[No Abstract] [Full Text] [Related]
31. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
32. Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
Coovadia H
N Engl J Med; 2004 Jul; 351(3):289-92. PubMed ID: 15247337
[No Abstract] [Full Text] [Related]
33. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
[TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda.
Bajunirwe F; Massaquoi I; Asiimwe S; Kamya MR; Arts EJ; Whalen CC
Afr Health Sci; 2004 Dec; 4(3):146-54. PubMed ID: 15687066
[TBL] [Abstract][Full Text] [Related]
36. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
[TBL] [Abstract][Full Text] [Related]
37. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
38. Immunopathological factors for vertical transmission of HIV-1.
Edgeworth RL; Ugen KE
Pathobiology; 2000; 68(2):53-67. PubMed ID: 10878502
[TBL] [Abstract][Full Text] [Related]
39. Feeding risk cut for HIV-infected women.
Das P
Lancet; 2003 Jul; 362(9380):300. PubMed ID: 12892984
[No Abstract] [Full Text] [Related]
40. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
